CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers

Immunity

Volumn 11, Issue 5, 1999, Pages 579-590

  Gandy, Kimberly L ^a,b   Domen, Jos ^a   Aguila, Hector ^a,c   Weissman, Irving L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN P 15095; T LYMPHOCYTE RECEPTOR;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DENDRITIC CELL; GENE REARRANGEMENT; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0033230515     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80133-8     Document Type: Article

References (58)

1. Aguila, H.L., Hershberger, R.J., and Weissman, I.L (1995). Transgenic mice carrying the diphtheria toxin A chain gene under the control of the granzyme A promoter: expected depletion of cytotoxic cells and unexpected depletion of CD8 T cells. Proc. Natl. Acad. Sci. USA 92, 10192-10196.
2. Aguila, H.L., and Weissman, I.L. (1996). Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells. Blood 87, 1225-1231.
3. Ashton-Rickardt, P.G., Bandeira, A., Delaney, J.R., Van Kaer, L., Pircher, H.P., Zinkernagel, R.M., and Tonegawa, S. (1994). Evidence for a differential avidity model of T cell selection in the thymus. Cell 76, 651-663.
4. Asiedu, C., Meng, Y., Wang, W., Huang, Z., Contreras, J.L., George, J.F., and Thomas, J.M. (1999). Immunoregulatory role of CD8alpha in the veto effect. Transplantation 67, 372-380.
5. Baker, M.B., Podack, E.R., and Levy, R.B. (1995). Perforin-and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice. Biol. Blood Marrow Transplant. 1, 69-73.
6. Bennett, M., Kumar, V., Mikhael, A., Murphy, W.J., Rembecki, R.M., Sentman, C.L., and David, C.S. (1987). Rejection of bone marrow cells by irradiated mice: NK and T cells recognize different antigens. Transplant. Proc. 19, 5-11.
7. Blazar, B.R., Hirsch, R., Gress, R.E., Carroll, S.F., and Vallera, D.A. (1991). In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment. J. Immunol. 147, 1492-1503.
8. Cai, Z., and Sprent, J. (1994). Resting and activated T cells display different requirements for CD8 molecules. J. Exp. Med. 179, 2005-2015.
9. Davenport, C., Haile, A., Kumar, V., and Bennett, M. (1995). Hybrid and allogeneic resistance to T cell grafts mediated by murine NK and CD8+ T cells. J. Immunol. 154, 2568-2577.
10. Deeg, H.J., Storb, R., Weiden, P.L., Shulman, H.M., Graham, T.C., Torok-Storb, B.J., and Thomas, E.D. (1979). Abrogation of resistance to and enhancement of DLA-nonidentical unrelated marrow grafts in lethally irradiated dogs by thoracic duct lymphocytes. Blood 53, 552-557.
11. Dennert, G., Andersen, C.G., and Warner, J. (1985). T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance. J. Immunol. 135, 3729-3734.
12. Domen, J., Gandy, K.L., and Weissman, I.L. (1998). Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 91, 2272-2282.
13. Drobyski, W.R., and Majewski, D. (1997). Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice. Blood 89, 1100-1109.
14. Filipovich, A.H., McGlave, P.B., Ramsay, N.K., Goldstein, G., Warkentin, P.I., and Kesey, J.H. (1982). Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation. Lancet 1, 1266-1269.
15. Fung-Leung, W.P., Schilham, M.W., Rahemtulla, A., Kundig, T.M., Vollenweider, M., Potter, J., van Ewijk, W., and Mak, T.W. (1991). CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65, 443-449.
16. Gandy, K.L., and Weissman, I.L. (1998). Tolerance of allogeneic heart grafts in mice simultaneously reconstituted with purified allogeneic hematopoietic stem cells. Transplantation 65, 295-304.
17. Gershenfeld, H.K., and Weissman, I.L. (1986). Cloning of a cDNA for a T cell-specific serine protease from a cytotoxic T lymphocyte. Science 232, 854-858.
18. Graubert, T.A., Russell, J.H., and Ley, T.J. (1996). The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood 87, 1232-1237.
19. Heeg, K., and Wagner, H. (1990). Induction of peripheral tolerance to class I major histocompatibility complex (MHC) alloantigens in adult mice: transfused class I MHC-incompatible splenocytes veto clonal responses of antigen-reactive Lyt-2+ T cells. J. Exp. Med. 172, 719-728.
20. Hershberger, R.J., Gershenfeld, H.K., Weissman, I.L., and Su, L. (1992). Genomic organization of the mouse granzyme A gene. Two mRNAs encode the same mature granzyme A with different leader peptides. J. Biol. Chem. 267, 25488-25493.
21. Hiruma, K., Hirsch, R., Patchen, M., Bluestone, J.A., and Gress, R.E. (1992). Effects of anti-CD3 monoclonal antibody on engraftment of T-cell-depleted bone marrow allografts in mice: host T-cell suppression, growth factors, and space. Blood 79, 3050-3058.
22. Ikuta, K., and Weissman, I.L. (1992). Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc. Natl. Acad. Sci. USA 89, 1502-1506.
23. Ildstad, S.T., Wren, S.M., Bluestone, J.A., Barbieri, S.A., Stephany, D., and Sachs, D.H. (1986). Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10. D2→B10). J. Immunol. 136, 28-33.
24. Kaufman, C.L., Colson, Y.L., Wren, S.M., Watkins, S., Simmons, R.L., and Ildstad, S.T. (1994). Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84, 2436-2446.
25. Korngold, B., and Sprent, J. (1978). Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J. Exp. Med. 148, 1687-1698.
26. Kumar, V., George, T., Yu, Y.Y.L., Liu, J., and Bennett, M. (1997). Role of murine NK cells and their receptors in hybrid resistance. Curr. Opin. Immunol. 9, 52-56.
27. Lapidot, T., Faktorowich, Y., Lubin, I., and Reisner, Y. (1992). Enhancement of T-cell-depleted bone marrow allografts in the absence of graft-versus-host disease is mediated by CD8+ CD4-and not by CD8-CD4+ thymocytes. Blood 80, 2406-2411.
28. Lee, L.A., Sergio, J.J., and Sykes, M. (1996). Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells. Transplantation 61, 125-132.
29. Luescher, I.F., Vivier, E., Layer, A., Mahiou, J., Godeau, F., Malissen, B., and Romero, P. (1995). CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 373, 353-356.
30. Martin, P.J. (1993). Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J. Exp. Med. 178, 703-712.
31. Martin, P.J., Akatsuka, Y., Hahne, M., and Sale, G. (1998). Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. Blood 92, 2177-2181.
32. Martin, P.J., and Kernan, N. (1990). T cell depletion for GVHD prevention in humans. In Graft Versus Host Disease: Research and Clinical Management, S. Burakoff, H.J. Deeg, J. Ferrar, and K. Atkinson, eds. (New York: Marcel Dekker, Inc.), pp. 371-387.
33. Martin, P.J., Rowley, S.D., Anasetti, C., Chancey, T.R., Gooley, T., Petersdorf, E.W., van Burik, J.-A., Flowers, M.E.D., Storb, R., Appelbaum, F.R., and Hansen, J.A. (1999). A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients. Blood 94, 2192-2199.
34. + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7, 493-504.
35. Morrison, S.J., and Weissman, I.L. (1994). The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1, 661-673.
36. Murphy, W.J., Bennett, M., Kumar, V., and Longo, D.L. (1992). Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation. J. Immunol. 148, 2953-2960.
37. Murphy, W.J., Kumar, V., and Bennett, M. (1987). Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J. Exp. Med. 166, 1499-1509.
38. Norment, A.M., Salter, R.D., Parham, P., Engelhard, V.H., and Littman, D.R. (1988). Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 336, 79-81.
39. Palathumpat, V., Dejbakhsh-Jones, S., and Strober, S. (1995). The role of purified CD8+ T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation. Transplantation 60, 355-361.
40. Prentice, H.G., Blacklock, H.A., Janossy, G., Bradstock, K.F., Skeggs, D., Goldstein, G., and Hoffbrand, A.V. (1982). Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet 1, 700-703.
41. Rinkevich, B., and Weissman, I.L. (1992). Allogeneic resorption in colonial protochordates: consequences of nonself recognition. Dev. Comp. Immunol. 16, 275-286.
42. Rodt, H., Thierfelder, S., and Eulitz, M. (1974). Anti-lymphocytic antibodies and marrow transplantation. 3. Effect of heterologous anti-brain antibodies on acute secondary disease in mice. Eur. J. Immunol. 4, 15-19.
43. Rosenstein, Y., Ratnofsky, S., Burakoff, S.J., and Herrmann, S.H. (1989). Direct evidence for binding of CD8 to HLA class I antigens. J. Exp. Med. 169, 149-160.
44. Rudd, C.E. (1990). CD4, CD8 and the TCR-CD3 complex: a novel class of protein-tyrosine kinase receptor. Immunol. Today 11, 400-406.
45. Rudd, C.E., Barber, E.K., Burgess, K.E., Hahn, J.Y., Odysseos, A.D., Sy, M.S., and Schlossman, S.F. (1991). Molecular analysis of the interaction of p56lck with the CD4 and CD8 antigens. Adv. Exp. Med. Biol. 292, 85-96.
46. Schwartz, E., Lapidot, T., Gozes, D., Singer, T.S., and Reisner, Y. (1987). Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors. J. Immunol. 138, 460-465.
47. Shizuru, J.A., Jerabek, L., Edwards, C.T., and Weissman, I.L. (1996). Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment. Biol. Blood Marrow Transplant. 2, 3-14.
48. Spangrude, G.J., Heimfeld, S., and Weissman, I.L. (1988). Purification and characterization of mouse hematopoietic stem cells. Science 241, 58-62.
49. Storb, R., Epstein, R.B., Bryant, J., Ragde, H., and Thomas, E.D. (1968). Marrow grafts by combined marrow and leukocyte infusions in unrelated dogs selected by histocompatibility typing. Transplantation 6, 587-593.
50. Sykes, M., Sheard, M., and Sachs, D.H. (1988). Effects of T cell depletion in radiation bone marrow chimeras. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD. J. Immunol. 141, 2282-2288.
51. Thomas, J.M., Verbanac, K.M., Carver, F.M., Kasten-Jolly, J., Haisch, C.E., Gross, U., and Smith, J.P. (1994). Veto cells in transplantation tolerance. Clin. Transplant. 8, 195-203.
52. Tiberghien, P., Longo, D.L., Wine, J.W., Alvord, W.G., and Reynolds, C.W. (1990). Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery. Blood 76, 1419-1430.
53. Uchida, N., Tsukamoto, A., He, D., Priera, A.M., Scollay, R., and Weissman, I.L. (1998). High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts. J. Clin. Invest. 101, 961-966.
54. Uchida, N., and Weissman, I.L. (1992). Searching for hematopoietic stem cells: evidence that Thy-1.1lo Lin-Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. J. Exp. Med. 175, 175-184.
55. Vremec, D., and Shortman, K. (1997). Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159, 565-573.
56. Wang, B.-Y., El-Badri, N.S., Cherry, and Good, R.A. (1997). Purified hematopoietic stem cells without facilitating cells can repopulate fully allogeneic recipients across entire major histocompatibility complex transplantation barrier in mice. Proc. Natl. Acad. Sci. USA 94, 14632-14636.
57. Ware, C.F., VanArsdale, S., and VanArsdale, T.L. (1996). Apoptosis mediated by the TNF-related cytokine and receptor families. J. Cell. Biochem. 60, 47-55.
58. Wu, L., Li, C.L., and Shortman, K. (1996). Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny. J. Exp. Med. 184, 903-911.